184 related articles for article (PubMed ID: 31983034)
1. Oral contraceptive use, bone mineral density, and bone turnover markers over 12 months in college-aged females.
Almstedt HC; Cook MM; Bramble LF; Dabir DV; LaBrie JW
J Bone Miner Metab; 2020 Jul; 38(4):544-554. PubMed ID: 31983034
[TBL] [Abstract][Full Text] [Related]
2. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence.
Cibula D; Skrenkova J; Hill M; Stepan JJ
Eur J Endocrinol; 2012 Jun; 166(6):1003-11. PubMed ID: 22436400
[TBL] [Abstract][Full Text] [Related]
3. Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.
Biason TP; Goldberg TB; Kurokawa CS; Moretto MR; Teixeira AS; Nunes HR
BMC Endocr Disord; 2015 Apr; 15():15. PubMed ID: 25990414
[TBL] [Abstract][Full Text] [Related]
4. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Nappi C; Di Spiezio Sardo A; Acunzo G; Bifulco G; Tommaselli GA; Guida M; Di Carlo C
Contraception; 2003 May; 67(5):355-9. PubMed ID: 12742557
[TBL] [Abstract][Full Text] [Related]
5. Combined Oral Contraceptives: Association with Serum 25-Hydroxyvitamin D and Calcium and Bone Homeostasis.
Donangelo CM; Cornes R; Sintes C; Bezerra FF
J Womens Health (Larchmt); 2024 Jun; 33(6):805-815. PubMed ID: 38417038
[No Abstract] [Full Text] [Related]
6. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
7. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
[TBL] [Abstract][Full Text] [Related]
8. Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.
Seguro LP; Casella CB; Caparbo VF; Oliveira RM; Bonfa A; Bonfa E; Pereira RM
Osteoporos Int; 2015 Feb; 26(2):459-67. PubMed ID: 25146092
[TBL] [Abstract][Full Text] [Related]
9. Bone impact after two years of low-dose oral contraceptive use during adolescence.
Orsolini LR; Goldberg TBL; Caldeirão TD; Cristiane da Silva C; Rizzo ADCB; Biason TP; Teixeira AS; Carvalho Nunes HR
PLoS One; 2023; 18(6):e0285885. PubMed ID: 37289781
[TBL] [Abstract][Full Text] [Related]
10. Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
Gersten J; Hsieh J; Weiss H; Ricciotti NA
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):635-642. PubMed ID: 27287084
[TBL] [Abstract][Full Text] [Related]
11. Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study.
Mwasakifwa GE; Amin J; White CP; Center JR; Kelleher A; Boyd MA
HIV Med; 2020 Sep; 21(8):492-504. PubMed ID: 32573910
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and bone density in adolescent and young adult women.
Scholes D; Ichikawa L; LaCroix AZ; Spangler L; Beasley JM; Reed S; Ott SM
Contraception; 2010 Jan; 81(1):35-40. PubMed ID: 20004271
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Schettino D; Nappi C
Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):388-93. PubMed ID: 23859010
[TBL] [Abstract][Full Text] [Related]
14. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
[TBL] [Abstract][Full Text] [Related]
15. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
Mok CC; Ho LY; Ma KM
Bone; 2015 Jun; 75():222-8. PubMed ID: 25761434
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation.
Scholes D; Hubbard RA; Ichikawa LE; LaCroix AZ; Spangler L; Beasley JM; Reed S; Ott SM
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1380-7. PubMed ID: 21752879
[TBL] [Abstract][Full Text] [Related]
17. Combined hormonal contraception and bone health: a systematic review.
Martins SL; Curtis KM; Glasier AF
Contraception; 2006 May; 73(5):445-69. PubMed ID: 16627030
[TBL] [Abstract][Full Text] [Related]
18. Observational Study to Evaluate the Effect of Epidural Steroid Injection on Bone Mineral Density and Bone Turnover Markers.
Jain A; Gupta P; Chaurasia R; Singh M; Pandey S
Pain Physician; 2020 Sep; 23(5):E517-E524. PubMed ID: 32967402
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls.
Almstedt Shoepe H; Snow CM
Osteoporos Int; 2005 Dec; 16(12):1538-44. PubMed ID: 15902418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
